Increased METEORIN-LIKE (ML) expression promotes lung inflammation in asthma.

X. Yao (Nanjing, China), X. Yan (Nanjing, China), M. Jia (Nanjing, China), J. Xu (Nanjing, China), Y. Meng (Nanjing, China), J. Jiang (Nanjing, China), X. Jiang (Nanjing, China), Y. Yang (Nanjing, China), Y. Ou (Nanjing, China), J. Zhou (Nanjing, China), S. Pavlidis (London, United Kingdom), S. Mumby (London, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), H. Jung (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea), M. Huang (Nanjing, China)

Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Session: Novel mechanisms elucidated by translational studies of asthma
Session type: Poster Discussion
Number: 5217
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Yao (Nanjing, China), X. Yan (Nanjing, China), M. Jia (Nanjing, China), J. Xu (Nanjing, China), Y. Meng (Nanjing, China), J. Jiang (Nanjing, China), X. Jiang (Nanjing, China), Y. Yang (Nanjing, China), Y. Ou (Nanjing, China), J. Zhou (Nanjing, China), S. Pavlidis (London, United Kingdom), S. Mumby (London, United Kingdom), F. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), H. Jung (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), Y. Cho (Seoul, Republic of Korea), T. Kim (Seoul, Republic of Korea), M. Huang (Nanjing, China). Increased METEORIN-LIKE (ML) expression promotes lung inflammation in asthma.. 5217

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Decreased Smad7 expression in the airways of a mouse model of chronic asthma
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004


Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007



Relationship between salivary markers of oxidative stress (OS) and different levels of control of bronchial asthma (BA).
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

IL-33/sST2 balance regulates neutrophilic inflammation in the human airways.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Increased numbers of airway wall plasma cells in smokers with chronic bronchitis: co-localization and gene expression for interleukin 4 and 5
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002

The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006



Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005


Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005

Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

Airway neutrophilia in chronic airways disease (CAD) is associated with lower lung function and reduced soluble(s)RAGE
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD)
Source: Eur Respir J 2007; 30: Suppl. 51, 110s
Year: 2007

The regulation of apoptosis in the induced sputum cells of patients with bronchial asthma (BA) using different therapeutic programms
Source: Eur Respir J 2003; 22: Suppl. 45, 79s
Year: 2003

The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012